Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Neuron|March 11, 2017
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesFiona M Menzies, Angeleen Fleming, Andrea Caricasole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United StatesMelissa A Rolfes, Alexander J Millman, Pamela Talley, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library ScreenSimon C C Lucas, Alexander G Milbradt, Jason Breed, et al.
The Lancet. Respiratory Medicine|October 21, 2015
Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigationClaire M Midgley, John T Watson, W Allan Nix, et al.
Communications Biology|May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTACThomas G Hayhow, Beth Williamson, Mandy Lawson, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12CJason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United StatesLina I Elbadawi, Pamela Talley, Melissa A Rolfes, et al.
Journal of Medicinal Chemistry|April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12CJason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Contemporary Clinical Trials|March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Pageof 13